A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
Recruiting · NCT02770066 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Aarhus
View the official record on ClinicalTrials.gov →Interventions studied
Percutaneous transluminal renal angioplasty
What this trial is about
A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- All of the following:
- At least one of the above eligibility criteria
- Duplex doppler ultrasonography or renography investigations consistent with hemodynamically significant renal artery stenosis
- CT angiography or renal arteriography with angiographic renal artery stenosis of ≥ 70 % reduction of the luminal diameter in at least one projection
Exclusion criteria
- If angiography/arteriography, ultrasonography or renography is consistent with bilateral significant renal artery stenosis and only one side is treated with PTRA
- PTRA of a renal artery supplying a kidney which pre-PTRA handles ≤ 10% of the total kidney function (with no blockage of the renin-angiotensin system) and has a kidney size \< 7 cm (length)
Where it is running
5 locations listed.
- Aalborg University Hospital - Aalborg, Denmark
- Aarhus University Hospital - Aarhus N, Denmark
- Glostrup University Hospital/ Rigshospitalet - Glostrup Municipality, Denmark
- Holbaek Hospital - Holbæk, Denmark
- Odense University Hospital - Odense C, Denmark